Paul Enever
Paul Enever is a partner and co-founder of Evidity Health Capital. He previously served as a partner at McKinsey and Company and worked in research and development.
What Paul can write
Evidity Health Capital writes $3M to $10M checks, larger than 93% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Evidity Health Capital.Career
- MIT’s Biotechnology Process Engineering Center
- Sandoz Pharmaceuticals
- McKinsey and Company · partner
- Evidity Health Capital · PartnerNow
Companies founded
Investments named in public bios
Focus
Education
Also at Evidity Health Capital
Partners like Paul
At firms with a similar stage, sector and check size.
Alert me when Evidity Health Capital is active
One email when Paul's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Paul Enever?
Paul Enever is a partner and co-founder of Evidity Health Capital. He previously served as a partner at McKinsey and Company and worked in research and development.
How much does Paul Enever invest?
Paul Enever invests through Evidity Health Capital, which writes checks of $3M to $10M at series b.
How do I pitch Paul Enever?
A warm intro from a founder Evidity Health Capital backed works best. A short LinkedIn note with one line on traction is the next best route.
What did Paul Enever do before Evidity Health Capital?
MIT’s Biotechnology Process Engineering Center; Sandoz Pharmaceuticals; partner at McKinsey and Company.
Last updated 2026-10-15. Is this you? Ask for a correction.